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Immune responses to a large number of antigens have been shown to be controlled by 
specific immune response fir) genes encoded within the major histocompatibility complex 
(MHC) ~  in several species (1). In the mouse, Ir genes have been mapped to a particular 
part of the MHC, termed the I  region (2). Although it has been proposed that specific Ir 
genes exert some or all of their effects at the level of activation of thymus-dependent (T) 
lymphocytes (3), this issue has been difficult to study directly in the mouse because of the 
lack of a reproducible assay system which exclusively measures T-lymphocyte function. 
Recently, however, we have introduced a reliable antigen-specific murine T-lymphocyte 
proliferation  assay  which  allows  for  direct  in  vitro  assessment  of this  aspect  of T- 
lymphocyte function (4). In this procedure, an enriched population of T lymphocytes is 
purified from thioglycollate-induced peritoneal exudates of immunized mice by passage 
over nylon wool columns. This population, termed PETLES, is exquisitely sensitive to 
antigen  and  yields  large  degrees  of proliferation  when  challenged  in  vitro  with  the 
immunizing antigen.  The  response  is  sensitive  to  pretreatment  with  anti-Thy  1 and 
complement(C),  and  exhibits  carrier  specificity.  Moreover,  as  we show in  this  paper, 
greater than 85% of the transformed cells bear the Thy 1 antigen while less than 5% bear 
surface immunoglobulin. Thus, the assay can be regarded as almost entirely a measure of 
T-lymphocyte function. 
In the present communication, we utilize the assay to examine the T-lympho- 
cyte proliferative responses to seven different antigens; the antibody responses 
to these antigens have previously been shown to be under the control of  Ir genes. 
We demonstrate here that a  close parallel exists between the genetic control of 
T-lymphocyte proliferation and that of antibody formation, suggesting that the 
same MHC gene controls both types of immune responsiveness. These observa- 
tions  make  it  appear  highly unlikely that Ir  genes  are  expressed  solely in  B 
lymphocytes, because  one  would expect that  mice  with  a  defect  limited  to  B 
lymphocytes would show a  normal T-lymphocyte proliferative response. 
Abbreviations  used in this paper: BSA-azide buffer, 2% bovine serum albumin and 0.2% NAN3; 
FCS, fetal calf serum; F1-RaMIG, fluorescein-conjugated rabbit antimouse IgG; GAT, poly(Glu  ~"- 
Ala3'Tyr~"); GLT, poly(Glu~SLys38Tyr4);  LDHB, porcine lactate  dehydrogenase H4; LPS, lipopoly- 
saccharide; MHC, major histocompatibility  complex; Nase, staphylococcal nuclease; PBS, phos- 
phate-buffered saline; PEC, peritoneal exudate cells; PETLES, peritoneal exudate T-lymphocyte- 
enriched cells; PPD, purified protein derivative of tuberculin; (¢b,G)-A--L,  poly-(Phe,Glu)-poly-D,L- 
Ala--poly-Lys;  (T,G)-A--L, poly-(Tyr,Glu)-poly-D,L-Ala--poly-Lys. 
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Materials and Methods 
Animals.  BALB/c  AnN  and  C3H/HeN  mice  were  obtained  from  the  Division of Research 
Services  of  the  National  Institutes  of  Health,  Bethesda,  Md.  Strains  B10.A(18R)  B10.HTT, 
B10.S(7R),  and B10.S(9R) were kindly provided by Dr.  Martin Dorf,  Department of Pathology, 
Harvard  Medical  School,  Boston,  Mass.  All  other  inbred  and  congenic  resistant  lines  were 
obtained from The Jackson Laboratory, Bar Harbor, Maine. Reciprocal F~ hybrid mice were bred 
in our own laboratory from the Jackson parental strains, C57BL/10Sn(B10) and B10.A/SgSn.  No 
maternal influence was noted in the ability of these F~ hybrids to respond to antigenic challenge. 
Mice were used between 6 and 24 wk of age,  and in any given experiment, mice of only one sex 
were used. 
Antigens.  The  linear random  terpolymers  poly(Glu'"~Ala3~)Tyr TM)  (GAT)  and  poly(Glu:'SLys  a~ 
Tyr  4)  (GLT)  were  synthesized  from  the N-carboxyanhydrides  of the  amino  acids  (5)  by  Pilot 
Chemical  Co.,  Inc.,  Boston,  Mass.;  and  Miles-Yeda,  Rehovot,  Israel,  respectively.  They  were 
dissolved in 1 N NaOH, neutralized to pH 7.2 and stored at concentrations of 2-10 mg/ml at -20°C. 
The branched chain synthetic copolymers poly-(Tyr,Glu)-poly-D,L-Ala--poly-Lys [(T,G)-A--L] and 
poly-(Phe, Glu)-poly-D,L-Ala--poly-Lys [(¢b,  G)-A--L] were the kind gifts of Doctors Michael Sela and 
Edna Mozes,  The Weizmann Institute of Science,  Rehovot, Israel (6).  These two antigens were 
dissolved directly in phosphate-buffered saline (PBS), pH 7.2, and stored at -20°C. Staphylococcal 
nuclease (Nase),  was purified from the extracellular broth of cultures of Staphylococcus  aureus, 
Foggi strain, as previously described (7) and a  3 mg/ml stock solution in distilled water was the 
kind gift of Dr. C. Garrison Fathman, NCI, NIH, Bethesda, Md. The IgA myeloma protein, TEPC 
15, was obtained from an ascites tumor (Litton Bionetics, Rockville, Md.) and purified by affinity 
chromatography  on  a  phosphorylcholine  column  according  to  the  procedure  of Chesebro  and 
Metzger (8). The p-nitrophenyl phosphorylcholine reagent was kindly provided by Dr. H. Metzger, 
NIAMDD, NIH, Bethesda, Md., and the organic coupling reactions were performed with the help 
of Dr. J.  K.  Inman, NIAID,  NIH,  Bethesda, Md.  Porcine lactate dehydrogenase H4 (LDHB)  was 
purchased from Boehringer Mannheim Corp.,  New  York,  dialyzed  against PBS,  centrifuged to 
remove aggregated material, sterilized by filtration through a 0.45 ~m Millipore filter, and stored 
at 4°C (9). Purified protein derivative of tuberculin (PPD) was purchased from Connaught Medical 
Research  Laboratory,  Willowdale,  Ontario,  as  a  2  mg/ml  solution  and  stored  at  -20°C.  All 
antigens were  diluted with culture  medium to appropriate  concentrations just before use.  The 
mitogen,  lipopolysaccharide (LPS), isolated from Salmonella typhosa,  was purchased from Difco 
Laboratories, Detroit, Mich. It was dissolved in PBS, sterilized by filtration, diluted with culture 
medium, and used at a  final concentration of 10 ~g/ml. 
Immunizations.  Mice  were  immunized  with  1-20  ~g  of  antigen  emulsified  in  complete 
Freund's adjuvant containing 1 mg/ml Mycobacterium tuberculosis,  strain H37Ra (Difco Laborato- 
ries). Each mouse received 0.1 ml of emulsion distributed equally between the two hind foot pads. 
Preparation  of PETLES.  2.5  wk  after  immunization,  mice  were  injected  intraperitoneally 
with 1 ml of 10% Brewer's thioglycollate (Difco Laboratories). 5 days later the peritoneal exudate 
cells  (PEC)  were  harvested  as  described  in  detail  elsewhere  (4).  Purification of the  lymphoid 
population previously involved adherence to glass followed by passage of the nonadherent cells 
over nylon wool columns. In the present studies this procedure was greatly simplified by eliminat- 
ing the glass adherence step and increasing the size of the nylon wool columns. 3.5 g of washed 
nylon wool were packed into a 35 ml syringe and used to fractionate 4-6 ×  l0  s PEC; 2.5-g columns 
in a  20 ml syringe were used for 2-3  ×  l0  s PEC.  The cells were incubated on the column for 1 h, 
with two 3- to 4-ml washes into the column at 15- and 30-min intervals. The nonadherent cells were 
eluted with 100 ml of EHAA culture medium (10) containing 10% heat-inactivated (56°C,  45 min) 
fetal calf serum (FCS). This population contained approximately twice as many macrophages as 
the peritoneal exudate T-lymphocyte-enriched cells (PETLES) described previously (4), but other- 
wise was very similar in composition. The mean composition using the new procedure was 13% 
macrophages,  55%  lymphocytes,  2%  B  lymphocytes  (identified  by  staining  with  fluorescein- 
conjugated  rabbit antimouse  immunoglobulin),  and  32%  eosinophils for  107  experiments.  The 
mean composition, using the old procedure was 7% macrophages, 54% lymphocytes, 2% B lympho- 
cytes,  and 39% eosinophils. The slight enrichment of macrophages in the new PETLES  did not 
affect their responsiveness to antigen. Proliferation ensued over as wide a dose range of antigen as 
before and the response was almost completely eliminated by pretreatment of the population with 
anti-Thy 1 antiserum plus C. RONALD  H.  SCHWARTZ  AND  WILLIAM  E.  PAUL  531 
Cell Cultures.  1 × 10  '~ PETLES were cultured in sterile, U bottom, polystyrene, microculture 
plates (Cooke Laboratory Products Div., Dynatech Laboratories Inc., Alexandria, Va.) containing 
0.2 ml of EHAA medium supplemented with 10% FCS and 10-50 gg/ml of gentamycin instead of 
streptomycin. Antigens were diluted to twice optimal concentrations (100 gg/ml for all antigens 
except PPD,  which  was  20  ~g/ml,  and  Nase  which  was  1  ~g/ml) with  supplemented  EHAA 
medium; 0.1 ml of diluted antigen was then mixed with 0.1 ml of cells. 
Cells were cultured for 5 days  at 37°C in a  humidified atmosphere of 2% CO2 and  98% air. 
Approximately 16-18 h before harvesting the cultures were pulsed with 1 ~Ci of tritiated-methyl- 
thymidine (sp act 5 Ci/mmol; Amersham/Searle Corp.,  Arlington Heights, Ill.) in 10 ~l of PBS. 
The  cultures  were  harvested  onto  glass  fiber filter paper  strips  with  a  MASH II automated 
harvestor (Microbiological  Associates, Rockville, Md.) and washed with distilled water and 95% 
ethanol.  The filter discs  for each  sample were placed in  2 ml of Hydromix scintillation fluid 
(Yorktown Research Inc., Hackensack, N. J.) and the radioactivity monitored in a Beckman liquid 
scintillation counter (Beckman  Instruments,  Inc.,  Fullerton,  Calif.).  All determinations  were 
done in triplicate and the data are expressed as counts per minute _+ standard error of the mean 
(SEM). 
Identification  of Dividing  Cells in Antigen-Stimulated PETLES.  2  ×  10  ~ PETLES per well 
were cultured in EHAA medium plus 10% FCS for 4 or 5 days in the presence of PPD or LPS. The 
cells were harvested by suspending with a Pasteur pipette. The pool of cells from 10 to 20 wells was 
separated on a Ficoll-Hypaque density gradient (p = 1.077) for 35 min at room temperature (11) to 
remove dead cells and debris. The interface population was recovered, washed twice with Eagle's 
minimal essential medium, and the cells counted. Recovery of live cells ranged from 10 to 33% of 
the initial number of PETLES plated. The cells were then washed twice at 4°C with a 0.15 M NaC1, 
0.05 M phosphate buffer, pH 7.2, containing 2% bovine serum albumin and 0.2% NaN.~ (BSA-azide 
buffer) (12) and divided into two groups. One was treated with anti-Thy 1.2 serum [raised in AKR 
mice by injection of C3H thymocytes as described by Reif and Allen (13)], the other with normal 
mouse serum. In each case 50 ~l of neat serum was used/10 ~ cells. The cells were incubated on ice 
for 30 min. They were then washed three times with the BSA-azide buffer and reacted for 30 min at 
4°C with fluorescein-conjugated rabbit antimouse IgG (F1-RaMIG) (both antiheavy and light chain 
specificities) (lot no.  6117; Cappell  Laboratories,  Inc.,  Dowingtown,  Pa.).  After another  three 
washes wet mounts were prepared and read. Blast cells were identified mainly on the basis of their 
large size  and  the  absence  of numerous  phagocytic vesicles (to  distinguish  them from macro- 
phages).  These  cells were  then  scored  as  positive or  negative for fluorescence using  a  Leitz 
orthoplan incident-illumination microscope  (E. Leitz, Inc., Rockleigh, N. J.), the details of which 
have been described previously (12). In the population stained with normal mouse serum and then 
F1-RaMIG,  positive cells were classified as B lymphocytes. In the population stained with anti- 
Thy 1.2 followed by F1-RaMIG, positive cells constituted both T and B lymphocytes. The percent- 
age of T-cell blasts was obtained by subtraction of the first from the second determinations. 
Results 
Demonstration  that Proliferating Cells are Principally  T  Lymphocytes.  We 
have previously demonstrated  that  antigen-induced proliferation of PETLES  is 
sensitive  to  pretreatment  with  anti-Thy  1  antiserum  and  C,  and  that  the 
response  exhibits  carrier  specificity (4).  In  addition,  since  B  lymphocytes,  as 
defined by staining with F1-RaMIG, are relatively rare in PETLES  (2.1  _+  0.3%, 
n  =  32),  it  seemed  reasonable  to  conclude  that  the  proliferative  response 
measured principally the participation of T  lymphocytes. However, because this 
assertion  is particularly  important  for the  use  of the  assay  in  the  study of Ir- 
gene-controlled systems, it seemed necessary to directly rule out any significant 
contribution of T-cell-dependent, B-lymphocyte proliferation to the total magni- 
tude of the proliferative response. The question was addressed by examining the 
surface markers  of the cells dividing in response to antigen. Blast cells obtained 
4 or 5 days after the stimulation of PETLES  with PPD were examined for either 
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experiments using immunofluorescence to identify surface markers and  mor- 
phological criteria to identify blasts, a mean of 5% of the blast cells was found to 
bear  immunoglobulin,  a  mean  of 85%  bore  Thy  1.2,  and  10%  bore  neither 
marker. In contrast, when PETLES were stimulated with the B-cell mitogen, 
LPS, 80% of the small number of recovered blasts bore immunoglobulin, demon- 
strating that if immunoglobulin-bearing cells made a  measurable contribution 
to the antigen-induced proliferative response, they should have been detected. 
We conclude from this study that 85% or more of the PETLES which proliferate 
in response to antigen are members of the T-lymphocyte line. 
Genetic  Control  of Antigen-Induced  T-Lymphocyte  Proliferation.  Murine 
antibody responses to a  variety of antigens have been shown to be under the 
control of  specific Ir genes located in the I region of  the MHC (1, 2). We evaluated 
the T-lymphocyte proliferative responses to seven of these antigens in a series of 
inbred mouse strains in order to study the genetic expression of Ir genes in a 
system devoid of B lymphocytes. Three classes of antigens were examined: the 
linear synthetic random terpolymers, GAT and GLT; the branched chain syn- 
thetic copolymers, (T,G)-A--L and ($,G)-A--L; and the protein antigens, LDHB, 
Nase, and TEPC-15. Mice were immunized with 1-20 ~g of antigen, emulsified 
in complete Freund's adjuvant. PETLES were prepared 3 wk later and 5 x  104, 1 
x  10  '~, and 2 x  10  ~ cells were challenged in vitro with 1, 10, or 100 ~tg/ml  of the 
immunizing antigen or with a  maximal stimulating concentration of PPD (20 
~g/ml). The PPD stimulation served as a positive control in each experiment to 
demonstrate that the failure of the cells to respond to an antigen in a genetically 
controlled system could not be  ascribed to a  nonspecific failure of the  assay. 
Representative results for each of the seven antigens,  using  1  x  10  :~ PETLES 
and the maximum stimulating antigen concentration (usually 100 ~g/ml), are 
shown in Tables I-III. 
Antigens in all three classes proved satisfactory for use in the proliferation 
assay, evoking significant tritiated thymidine incorporation into PETLES from 
responder strains,  although generally less than the incorporation seen by the 
same  cells in response to PPD.  Strains designated as  nonresponders to these 
antigens showed no statistically significant difference (Student's t  test) in the 
counts  per  minute  incorporated in the  presence of antigen,  compared to the 
counts per minute incorporated in the presence of medium alone. In all cases, 
nonresponder strains showed excellent responses to PPD. Furthermore, strains 
which  were  nonresponders  to  any  one  of the  seven  antigens  were  always 
responders to several of the other antigens. 
It was usually possible to unambiguously designate strains tested as respond- 
ers or nonresponders; however, in the case of the protein antigens LDHB and 
Nase, some strains mounted a weak but significant response at higher immuniz- 
ing doses. LDHs elicited no response from B10.A/SgSn mice when these animals 
were immunized with a  low dose of the antigen (1  ~g) but it did elicit a  weak 
response when the mice were immunized with a higher dose of antigen (10 ~tg). 
This response was always less than that given by a  responder strain at either 
immunizing dose [compare B10.A(10):  Acpm of 2,800;  E/C-1 of 1.5 with B10(1): 
Acpm  of 41,100,  E/C-1  of 4.4  or  with  B10(10):  Acpm  of 17,400;  E/C-1  of 5.9]. 
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TABLE I 
Genetic Control of the T-Lymphocyte Proliferative Response to GAT, GLT, Nase, LDH., and 
( q),G  )-A--L * 
Respond- 
Antigens  Strains~  Medium  Antigen  PPD  ers§ 
GAT  C57BL/10Sn (10)  2,800  ±  800  22,800  ±  2,400  71,900  ±  1,500  ++ 
C3H/HeN (10)  580  ±  130  18,000  ±  1,200  42,400  ±  900  ++ 
SJL/J (10)  4,100  ±  1,700  3,200  ±  500  69,200  ±  9,000  - 
DBA/1J (10)  3,600  ±  500  3,800  ±  300  44,300  ±  2,300  - 
GLT  BALB/cAnN (10)  2,400  ±  100  18,900  ±  2,300  124,700  +  11,100  ++ 
B10.D2/nSn (10)  450  ±  60  32,500  ±  4,500  59,600  ±  4,600  + + 
SJL/J (10)  5,200  ±  1,300  3,600  ±  700  48,100  ±  2,400 
C57BL/10Sn (10)  1,600  ±  500  2,200  ±  600  23,300  ±  2,600 
Nase  SJL/J (10)  2,200  ±  300  134,900  ±  8,300  179,000  ±  5,000  + + 
SJL/J (1)  3,900  ±  1,300  90,900  ±  11,600  170,000  ±  4,100  ++ 
BALB/c AnN (10)  2,200  ±  400  61,000  ±  5,200  112,000  ±  1,600  ++ 
DBA/1J (10)  2,300  _+  1,100  2,200  ±  500  29,100  ±  50  - 
C57BL/10Sn (10)  1,100  ±  400  6,000  ±  500  46,900  ±  2,500  + 
C57BL/10Sn (1)  1,400  ±  400  1,300  ±  200  40,500  ±  800 
LDH~  C57BL/10Sn (10)  2,600  ±  800  18,000  ±  2,000  43,500 ±  3,500  ++ 
C57BL/10Sn (1)  9,400  ±  800  50,500  ±  2,600  79,500  ±  4,900  ++ 
SJL/J (10)  3,700  ±  1,300  28,500  ±  3,900  67,800  ±  7,000  ++ 
AKR/J (10)  1,000  ±  200  3,800  ±  1,I00  36,400 ±  900  + 
B10.A/SgSn (10)  1,900  _+ 800  4,700  ±  1,300  92,000  ±  4,700  + 
B10.A/SgSn (1)  2,300  ±  700  2,900  ±  900  163,500  ±  6,500  - 
(dP,G)-A--L  C57BL/10Sn (20)  1,800  ±  200  28,500  ±  1,700  53,000  ±  9,300  + + 
B10.BR/SgSn (20)  1,300  ±  300  51,900  ±  400  78,600  ±  4,400  ++ 
B10.A/SgSn (10)  370  ±  10  16,800  ±  1,000  45,700  ±  4,600  ++ 
B10.M/Sn (20)  1,000  ±  100  1,100  ±  200  18,000  _+  1,200  - 
SJL/J (10)  3,200  ±  250  4,900  ±  1,900  49,300  ±  9,600 
* Mice were immunized with 1-20 ttg of antigen in CFA 3-5  wk before collection and preparation of PETLES. 1 ×  105 
cells were cultured with 1,  10, or 100 t~g/ml of the immunizing antigen, with 20- 40 tLg/ml of PPD, or with medium 
alone. Stimulation was assessed 5 days later by measuring the incorporation of an 18 h pulse of tritiated thymidine. 
The data are expressed as the mean counts per minute ± the standard error of the mean for triplicate determinations. 
For the antigen-stimulated cultures only the data from the concentration giving the largest stimulation are shown. 
This was generally 100 tLg/ml for GAT, GLT, LDHH, and (¢P,G)-A--L,  and 1 tLg/ml for Nase. 
$ The numbers in parentheses after each strain indicate the immunizing dose of the antigen in micrograms. 
§ Strains were assigned a nonresponder status (-) if the incorporation of thymidine in the presence of the immunizing 
antigen was not  significantly different by a  Student's t  test from the  incorporation of thymidine in the medium 
controls. Responder strains were divided into weak ( + ) and strong ( + + ) categories depending on the magnitude of the 
statistically significant response. Strong responders gave E/C-1 of 4 or more while weak responders gave E/C-1 of <4. 
cases it seems more appropriate to refer to the strains as "low responders." 
In each instance, with one exception to be discussed subsequently, the desig- 
nation of responder or nonresponder assigned to a strain based on the capacity of 
its  T  lymphocytes  to  proliferate  in  vitro  was  the  same  as  the  designation 
previously given the strain on the basis of its in vivo antibody response (1, 2). 
This  is  shown  most  clearly  in  Tables  II  and  III,  which  present  studies  of 
responsiveness  to  (T,G)-A--L  and  TEPC-15  by  an  extensive  series  of mouse 
strains,  including congenic  mice  bearing H-2  recombinant  chromosomes.  For 
both  antigens  it  is  possible  to  map  the  locus  of the Ir  gene  controlling the 
proliferative response in the same manner as was done for the antibody response 
(14,  15).  The  strain  distribution  patterns  of responsiveness  demonstrate  an 
association between Ir genes and the MHC.  For example,  strains having the b 
and d H-2 haplotypes were responders to (T,G)-A--L, whereas strains with the a, 
k,  r,  and  s  haplotypes  were  nonresponders.  The  fact  that  responsiveness  is 534  GENETIC  CONTROL  OF  MURINE  T-LYMPHOCYTE  PROLIFERATION 
Genetic 
Strain 
TABLE  II 
Control of the T-Lymphocyte Proliferative  Response  to (T,G)-A--L* 
MHC alleles*  Proliferative response to: 
Responders§ 
K, A, B,  C,  S,  D  Medium  (T,G)-A--L  PPD 
cpm  +- SEM 
A/WySn  k  k  k  d  d  d  3,400  -+  2,200  3,800  _+ 2,400  57,600  +_ 3,400 
C57BL/1OSn  b  b  b  b  b  b  800  ±  200  65,500 ±  6,700  71,200 ±  4,000  ++ 
BALB/cAnN  d  d  d  d  d  d  2,400  ±  200  22,200  ±  4,800  126,900  ±  17,000  ++ 
DBA/2J  d  d  d  d  d  d  5,500  ±  2,800  38,100  -+ 6,600  83,300  ±  10,200  ++ 
C3H/HeN  k  k  k  k  k  k  3,000  ±  700  3,300  -+  200  36,600  ±  700 
AKR/J  k  k  k  h  k  k  2,800  ±  200  4,300  -+ 600  21,700  ±  4,100 
RIII  r  r  r  r  r  r  10,500  ±  2,300  12,200  ±  500  50,900  -+ 4,200 
SJL/J  s  s  s  s  s  s  3,400  ±  1,900  4,200  -+  400  188,800  ±  11,000 
A.By/Sn  b  b  b  b  b  b  1,1O0  +- 300  10,900  +_  1,500  7,600  ±  2,000  ++ 
B10.A/SgSn  k  k  k  d  d  d  3,500  ±  400  4,000  ±  800  81,800  -+ 3,900 
B10.D2/nSn  d  d  d  d  d  d  3,200  ±  500  46,600  ±  2,800  64,600  ±  5,000  ++ 
B10.BR/SgSn  k  k  k  k  k  k  2,300  ±  50  2,100  _+ 600  69,900  +- 2,500  - 
(B10  x  B10.A)F~  k  k  k  d  d  d~  5,700  ±  1,300  76,000  _+  8,700  163,500  ±  22,000  ++ 
bbbbbb 
B10.A(18R)  b  b  b  b  b  d  6,200  -+ 400  47,600  -+  2,000  121,200  ±  5,600  ++ 
B10.A(5R)  b  b  b  d  d  d  1,200  -+  300  33,300  ±  1,800  50,600  -+ 4,200  ++ 
B10.A(4R)  k  k  b  b  b  b  4,400  ±  1,500  5,300  ±  1,600  239,700  _+  10,500  - 
B10.A(2R)  k  k  k  d  d  b  1,900  -+  100  3,000 ±  800  38,200  ±  1,500 
* Mice were immunized with 20 tLg of (T,G)-A--L  in CFA 3 wk before collection and preparation of PETLES. 1 ×  105 cells 
were cultured for 5 days with 100 ttg/ml of (T,G)-A--L, 20 ttg/ml of PPD, or medium alone. Stimulation was assessed by 
measuring the incorporation of an 18 h pulse of tritiated thymidine. The data are expressed as the mean counts per 
minute -+ the standard error of the mean for triplicate determinations. 
* Letters indicate the haplotype source of the genetic information for each region or subregion of the major histocompat- 
ibility complex (MHC), A, B, and C  designate the I-A, I-B,  and I-C subregions, respectively. 
§ See last legend of Table I. 
TABLE  III 
Genetic Control of the T-Lymphocyte Proliferative  Response  to TEPC 15" 
Strain  MHC  alleles*  IgAC.§  Proliferative response (cpm -+ SEM) to: 
K, A, B,  C, S,  D  allotype  Medium  TEPC 15  PPD 
Respond- 
ersll 
C57BL/10Sn  b  b  b  b  b  b  A '~  2,000  _+ 200  1,900  _+ 200  31,100  ±  1,600  - 
BALB/cAnN  d  d  d  d  d  d  A,~. ,3.  ,4  1,300  ±  400  2,400 -+ 500  67,200 *- 2,800  - 
AL/AnN  k  k  k  k  k  d  Ai3. ~7  4,100  _+  1,1O0  20,700  _+ 3,000  32,600  _* 2,400  ++ 
AKR/J  k  k  k  k  k  k  A,3. ~7  1,900  -+ 800  29,300  ±  1,100  96,600  ~+ 4,200  ++ 
C3H/HeN  k  k  k  k  k  k  A,~. ,3.  ,4  2,200  ±  200  3,000  _+ 500  94,400  ±  10,400  - 
RIII  r  r  r  r  r  r  A  14,100  ±  800  36,900  _+ 400  113,600  ±  4,600  + 
SJL/J  s  s  s  s  s  s  A ''~  300  _+ 40  400  ±  50  81,300  _+  12,500  - 
A.By/Sn  b  b  b  b  b  b  A,3. ,7  4,100 ±  700  5,200  _+  1,400  42,900  _+  1,000  - 
B10.A/SgSn  k  k  k  d  d  d  A '5  1,800  ±  800  49,800  ±  3,000  129,700  _~ 6,700  ++ 
B10.D2/nSn  d  d  d  d  d  d  A ''~  580  ±  110  670  ±  60  12,300  ~  1,400  - 
B10.BR/SgSn  k  k  k  k  k  k  A '~  3,900  ±  1,400  36,700 ±  4,400  148,100  ±  3,300  ++ 
B10.HTT  s  s  s  k  k  d  A '5  3,300  _+  1,300  17,100  ±  800  35,300 -*  6,500  ++ 
B10.S (9R)  s  s  s  d  d  d  A ''~  5,700 ±  1,100  14,500  ±  1,300  41,100 _*  2,100  + 
B10.S (7R)  s  s  s  s  s  d  A '5  9,800  ±  600  19,100  _+  1,800  56,700  _*  1,700  + 
(B10 x  B10.A)F,  k  k  k  d  d  d~  A '~  1,600  ±  400  19,400  ±  2,000  63,700 ±  3,700  ++ 
bbbbbb 
B10.A (5R)  b  b  b  d  d  d  A ''~  2,600  -+ 400  3,300  ±  800  72,200  _~  11,800  - 
B10.A (4R)  k  k  b  b  b  b  A '5  2,200  _+  300  23,100  ±  700  85,400  ±  10,000  ++ 
B10.A (2R)  k  k  k  d  d  b  A ~5  1,700  -+ 700  44,500  ±  1,200  75,000  ±  3,800  ++ 
* Mice were immunized with  20 pg  of  the  BALB/c IgA myeloma protein,  TEPC-15, in  CFA 3 wk before  collection  and 
preparation  of  PETLES. 1 × 105  cells  were  cultured  for  5  days  with  200 ~g/ml  of  TEPC-15,  20  ~g/ml  of  PPD,  or  medium 
alone.  Stimulation was  assessed  by  measuring  the  incorporation  of  an 18  h pulse  of  tritiated  thymidine. The  data  are 
expressed as  the  mean counts per minute ± the  standard  error  of  the  mean for  triplicate  determinations. 
* See  same legend of  Table If. 
§  IgAC.-allotypic  determinants  are  designated according to  the  Potter-Lieberman  nomenclature  (16).  The  BALB/c IgA 
myeloma protein,  TEPC-15 expresses A ~'2.  TM ~4  allotypic  determinants. 
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indeed coded for by genes  in the  MHC  was  shown in the  experiments with 
congenic  resistant  lines.  For  (T,G)-A--L,  the  B10  strain  was  a  responder, 
whereas the congenic lines B10.A and B10.BR,  which possess a  and k  MHC 
haplotypes, respectively, on a B10, non-MHC background, were nonresponders. 
Thus, the B10 MHC genes are essential for responsiveness to (T,G)-A--L. Con- 
versely, when the MHC genes of B10 were associated with the non-MHC genes 
of nonresponder A mice, as is found in the congenic strain, A. BY, the mice were 
responders. Thus, MHC genes are sufficient in themselves to confer responsive- 
ness to the animal. A similar analysis can be made for the response to TEPC 15. 
Responsiveness appeared to be a dominant genetic trait as shown by the ability 
of (B10  ×  B10.A)F~ mice to respond to both (T,G)-A--L and TEPC 15. 
Mapping  of the  Ir  Genes  Controlling  the  T-Lymphocyte  Proliferative  Re- 
sponses  to  (T,G)-A--L and  TEPC-15 to  the K  or I-A  Region  of the  MHC.  A 
more precise localization of the genes controlling immune responsiveness was 
made by examining the responses of a/b  MHC haplotype recombinant strains 
(Tables II and III). B10.A (5R) mice derive the K, I-A,  and I-B regions of their 
MHC from the b halpotype and the I-C, S, and D regions from the a  haplotype. 
This strain was a responder to (T,G)-A--L, a trait associated with the b haplo- 
type. This indicates that one Ir gene, which allows the b haplotype to respond, 
lies to the left ofI-C. B10.A(2R)  and B10.A(4R) mice, on the other hand, failed to 
respond to (T,G)-A--L. The latter recombinant was the most important since it 
possesses K  and I-A regions derived from the a haplotype and I-B, I-C, S, and D 
regions derived from the b  haplotype. The failure of the B10.A(4R)  to respond 
indicates that one gene allowing the b haplotype to respond must lie to the left of 
I-B, presumably in the K or I-A regions, but possibly to the left of  K, outside of 
MHC. By applying similar reasoning to the responses of these mice to TEPC-15, 
one can locate one locus controlling responsiveness to this antigen as also being 
to the left of I-B.  In this case, however, responsiveness is determined by the a 
haplotype and nonresponsiveness by the b haplotype. These results are precisely 
the same as those which were obtained by examining the antibody responses of 
these strains to both (T,G)-A--L and TEPC-15 (14, 15). 
Antibody responses to TEPC-15, which is a BALB/c IgA myeloma protein, are 
actually determined by two genetic loci, the  MHC-linked Ir  genes,  in which 
possession of a responder allele allows a response to occur, and the IgCH region, 
in which sharing of the BALB/c IgA allotype prevents a response (16). Table III 
shows that the same is true for T-lymphocyte proliferation. AKR and B10.BR 
mice possess the H-2 k haplotype as well as an allotypic form of IgA different 
from that  of the  BALB/c.  These  strains  both  show  substantial  proliferative 
responses to TEPC-15. On the other hand, C3H mice, although bearing the same 
responder allele in the MHC as AKR and B10.BR, nevertheless fail to respond to 
TEPC-15 because they possess IgA molecules of  the same allotype as BALB/c. 
One other point should be noted about the data in Table III. The SJL/J strain 
failed to respond to TEPC-15 (despite multiple attempts, including boosting), yet 
recombinant strains carrying the H-2" genes in the K  and I-A regions, such as 
B10.HTT,  B10.S(7R),  and B10.S(9R),  were responders,  although rather weak 
ones. The results obtained with recombinant strains parallel the findings for the 
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result with  the  SJL strain  does  not.  The reason  for this  single exception is 
unknown. 
The major conclusion to be drawn from these experiments is that the genetic 
control of the T-lymphocyte proliferative response in mice closely parallels the 
genetic capacity of  these animals to generate an antibody response. This correla- 
tion  suggests  that  the  same  immune  response  gene  controls  both  types  of 
responses.  Because the proliferative assay is almost completely devoid of any 
contribution from B  cells,  it  seems  quite  unlikely that  any of the Ir  genes 
controlling responses to the seven antigens studied can be expressed solely in B 
lymphocytes. 
Discussion 
In  this  paper  we  have  used  the  antigen-induced proliferative response  of 
mouse PETLES to assay T-lymphocyte function in Ir-gene-controlled systems. 
Although studies of this type have been reported previously, notably for DNA 
synthetic responses of guinea pig T lymphocytes (17), the superior understand- 
ing of MHC genetics in the mouse makes an asesssment ofT-cell function in this 
species  particularly important.  Furthermore,  recent  studies  of collaboration 
between  B  cells  and  helper  T  cells  (or  T-cell  factors),  in  immune responses 
controlled by specific Ir genes, have suggested that the locus of expression of at 
least  some  Ir-gene  products  is  in  the  B  lymphocyte rather  than  in  the  T 
lymphocyte (18, 19). The  proliferative  response  of PETLES  allows  a  direct 
examination of T-lymphocyte function in mice with such proposed B-lymphocyte 
defects. 
As a  prelude to the analysis of the proliferative response of PETLES in Ir- 
gene-controlled systems, it was mandatory to establish that this assay, indeed, 
measured only T-lymphocyte function. We have previously shown that very few 
B cells are present in PETLES (2%), that the response of PETLES to antigen can 
be essentially eliminated by pretreatment with anti-Thy 1.2 and C, and that the 
responding cells exhibit carrier specificity. In this paper we further show that at 
least 85% of the blast cells which appear after antigen stimulation bear the Thy 
1.2  marker and that only 5%  bear detectable surface immunoglobulin. Thus, 
from this extensive series of criteria it seems quite clear that the proliferative 
response of PETLES to antigen can be regarded as predominantly reflecting T- 
lymphocyte function. 
We  then  studied the  responsiveness of PETLES from mice  immunized to 
seven individual antigens, the antibody responses to which are  known to be 
under  the  control  of specific Ir  genes.  In  each  case,  PETLES from  animals 
previously designated as  responders by serum  antibody responses  (1,  2)  dis- 
played  substantial  incorporation  of tritiated  thymidine when  stimulated  in 
vitro. Similarly, PETLES from animals previously classified as low or nonre- 
sponders on the basis of serum antibody titers showed either no or only modest 
net incorporation of tritiated thymidine when confronted with antigen in vitro. 
This  concordance  in  assignment of responder  status  by  examining antibody 
production and T-cell proliferative responses suggests that the same Ir genes (or 
very closely linked genes)  control both types of immune responses.  Further- 
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PETLES  from  such  "nonresponders"  should  mount  a  normal  T-lymphocyte 
proliferative response. Since this was not the case, we conclude that none of the 
Ir genes studied in these experiments  are expressed exclusively in B  lympho- 
cytes. 
This point seems especially germane for the immune response to (T,G)-A--L. 
In our hands,  all mice classified as nonresponders by antibody assay proved to 
also be nonresponders in the proliferation assay. In particular,  mice of the H-2 k 
haplotype,  including  B10.BR/SgSn,  AKR/J,  and  C3H/HeN  were  all  nonre- 
sponders.  Similarly,  Lonai  and  McDevitt  (20)  have  previously  reported  that 
lymph node cells from (T,G)-A--L immunized C3H/DiSn mice, which are also H- 
2 k, fail to proliferate when cultured in vitro with (T,G)-A--L. On the other hand, 
Lichtenberg et al.  (18) have demonstrated by limiting dilution adoptive trans- 
fers that bone marrow of H-2 k mice contains reduced numbers of B-cell precur- 
sors with specificity for (T,G)-A--L, whereas precursors of specific T cells derived 
from  thymuses  of strains  of this  haplotype  appear  to  be present  in  normal 
amounts.  In addition,  Taussig et al.  (19) have reported that  spleen cells from 
irradiated H-2 k mice, reconstituted with syngeneic thymocytes and immunized 
with  (T,G)-A--L,  produce a  specific factor which  aids bone marrow cells from 
other  strains  to  respond.  In  the  latter  experiments,  H-2 k  mice  appear  to  be 
nonresponders  because their  B  cells are unable to bind the cooperating factor 
(21). Thus,  both  Lichtenberg  et  al.  and  Taussig  et  al.  classify H-2 k  mice  as 
nonresponders  because  they  appear  to  have  a  defect  in  their  B-lymphocyte 
function,  while  we  classify H-2 k  mice  as  nonresponders  because they fail  to 
develop a  T-lymphocyte proliferative response. 
Although these results are in apparent contrast to each other, several ways to 
make  them  consistent  can  be proposed.  It  is  possible that  the  nonresponder 
allele  for  the  (T,G)-A--L Ir  gene,  which  mice  of the  H-2  k haplotype  have,  is 
expressed in both B lymphocytes and T lymphocytes, but that some T-lympho- 
cyte functions, such as the production of collaborative factors, are not controlled 
by this Ir-gene product,  while others,  such as T-lymphocyte proliferation,  are 
critically dependent on the expression of a responder allele. As a variant on this 
approach, it might be postulated that the (T,G)-A--L nonresponder allele in the 
H-2 ~  haplotype  is expressed in  B  lymphocytes and  in  certain  subclasses of T 
lymphocytes (22). The cells important in factor production and perhaps in helper 
function might be a set of T lymphocytes whose activation does not require the 
expression of the responder allele. Proliferation, on the other hand, might be the 
initial response of a set of T lymphocytes which required the function of this Ir- 
gene product. Alternatively, the proliferative response might require the action 
of a  T  cell analogous to the factor producing cell, in order to activate the cell 
capable of proliferation. In this case, an analogy between the proliferating T cell 
and  the  B  cell could be drawn  in that  both would be "helped"  by the  factor- 
producing cell. 
Another possibility is that the (T,G)-A--L nonresponder allele in H-2 k mice is 
expressed  in  macrophages,  as  well  as  B  lymphocytes,  but  not  at  all  in  T 
lymphocytes. The antigen-induced proliferation of guinea pig T lymphocytes has 
been shown to be dependent  upon the presence of macrophages (23).  Further- 
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guinea pigs, macrophages from the responder parent are much more effective at 
presenting antigen than  macrophages from the  nonresponder parent  (24). If 
similar macrophage dependence can be  shown for the proliferation of mouse 
PETLES, then having macrophages express Ir-gene functions would seem to be 
a most attractive possibility. However, in order to explain the differing results of 
the factor production and the proliferation assays, it would also be necessary to 
postulate that both priming and in vitro activation of factor-producing T lym- 
phocytes are not macrophage dependent. 
In this  discussion of the  (T,G)-A--L system,  we  have  not  considered  mice 
which possess  a  nonresponder allele  at  the Ir  locus that  functions in  factor 
producing T lymphocytes, as defined by Taussig et al. (21). Mice, such as B10.M 
(H-2r), fail to produce-T-cell factor but display normal B-cell acceptor function 
(21).  Studies  on  the  proliferative  responses  of H-2  f  mice  and  of F~  hybrids 
between the two types of nonresponders,  such as  (H-2  k  ×  H-20,  are  now in 
progress. 
Summary 
The recent introduction of a reliable, T-lymphocyte proliferation assay, which 
utilizes thioglycollate-induced, nylon wool column-passed, peritoneal exudate 
lymphocytes  from immune mice (PETLES), allowed us to investigate the genetic 
control of murine immune responses at the T-lymphocyte level. Examination of 
the  blast  cells  generated  in  this  population  5  days  after  stimulation  with 
antigen, revealed that 85% of the cells bore the Thy 1 antigen on their surface, 
whereas only 5% bore immunoglobulin. Thus, the assay can be considered to 
measure  almost  exclusively T-lymphocyte function.  This  assay was  used  to 
examine the T-lymphocyte proliferative responses to seven different antigens: 
poly(Glu~°Ala3°Tyrl"),  poly(Glu'~Lys38Tyr4),  poly-(Tyr,Glu)-poly-D,L-Ala--poly- 
Lys, poly-(Phe,Glu)-poly-D,L-Ala--poly-Lys,  staphylococcal nuclease, lactate de- 
hydrogenase H4,  and the  BALB/c IgA  myeloma protein,  TEPC-15.  PETLES 
from a large number of different inbred mouse strains, including H-2 congenic 
resistant lines and H-2 recombinants, were studied. The strains could be classi- 
fied as high responders, low responders, or nonresponders to a particular anti- 
gen as judged by the magnitude of the T-lymphocyte proliferative response. In 
every case but one this classification corresponded to the responder status given 
the strain based on its ability to mount an in vivo antibody response to the same 
antigen.  For  two  of the  antigens,  poly-(Tyr,Glu)-poly-D,L-Ala--poly-Lys and 
TEPC-15,  the immune response genes controlling the T-lymphocyte prolifera- 
tive  response  were  mapped  to  the K  region  or I-A  subregion  of the  major 
histocompatibility complex, as had previously been shown for the control of the 
antibody responses to these antigens. This tight linkage of the two phenotypic 
responses very strongly suggests that the same immune response gene controls 
the expression of both the proliferative and antibody responses. Since there is 
essentially no contribution from B lymphocytes in the T-lymphocyte prolifera- 
tion  assay,  it  seems reasonable  to  conclude that none of the  seven  immune 
response genes studied are expressed solely in B lymphocytes. 
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